U.S. health regulators have for the first time cleared a Covid-19 vaccine’s use in children, paving the way for many to be immunized before summer camps and the start of the next school year.Millions of people ages 16 years and older have taken the shot from Pfizer Inc.
and partner BioNTech SE. The U.S. Food and Drug Administration’s decision Monday widens the vaccine’s use to children as young as 12.The move comes after a study of 2,260 adolescents found the two-dose shot worked safely in that age group.Its expanded use is expected to boost a vaccination campaign seeking to immunize as many people as possible before dangerous variants able to elude shots emerge.